181 related articles for article (PubMed ID: 36703897)
21. Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
Arnold N; O'Toole V; Huynh T; Smith HC; Luxford C; Clifton-Bligh R; Eastman CJ
Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31751313
[TBL] [Abstract][Full Text] [Related]
22. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
Hawkes CP; Li D; Hakonarson H; Meyers KE; Thummel KE; Levine MA
J Clin Endocrinol Metab; 2017 May; 102(5):1440-1446. PubMed ID: 28324001
[TBL] [Abstract][Full Text] [Related]
23. CYP24A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia.
Madsen JOB; Sauer S; Beck B; Johannesen J
J Clin Res Pediatr Endocrinol; 2018 Mar; 10(1):83-86. PubMed ID: 28874334
[TBL] [Abstract][Full Text] [Related]
24. AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.
Trutin I; Škorić I
Acta Clin Croat; 2022 Feb; 60(3):544-547. PubMed ID: 35282483
[TBL] [Abstract][Full Text] [Related]
25. A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.
Ferraro PM; Minucci A; Primiano A; De Paolis E; Gervasoni J; Persichilli S; Naticchia A; Capoluongo E; Gambaro G
Urolithiasis; 2017 Jun; 45(3):291-294. PubMed ID: 27639704
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic Infantile Hypercalcemia, Presenting in Adulthood--No Longer Idiopathic Nor Infantile: Two Case Reports and Review.
Tray KA; Laut J; Saidi A
Conn Med; 2015; 79(10):593-7. PubMed ID: 26731879
[TBL] [Abstract][Full Text] [Related]
27. 3' Untranslated Region Structural Elements in CYP24A1 Are Associated With Infantile Hypercalcemia Type 1.
Ball N; Duncan S; Zhang Y; Payet R; Piec I; Whittle E; Tang JCY; Schoenmakers I; Lopez B; Chipchase A; Kumar A; Perry L; Maxwell H; Ding Y; Fraser WD; Green D
J Bone Miner Res; 2023 Mar; 38(3):414-426. PubMed ID: 36625425
[TBL] [Abstract][Full Text] [Related]
28. Three Sisters With Heterozygous Gene Variants of
Hedberg F; Pilo C; Wikner J; Törring O; Calissendorff J
J Endocr Soc; 2019 Feb; 3(2):387-396. PubMed ID: 30729229
[TBL] [Abstract][Full Text] [Related]
29. When a maternal heterozygous mutation of the CYP24A1 gene leads to infantile hypercalcemia through a maternal uniparental disomy of chromosome 20.
Hureaux M; Chantot-Bastaraud S; Cassinari K; Martinez Casado E; Cuny A; Frébourg T; Vargas-Poussou R; Bréhin AC
Mol Cytogenet; 2021 May; 14(1):23. PubMed ID: 33952337
[TBL] [Abstract][Full Text] [Related]
30. Duplex high resolution melting analysis (dHRMA) to detect two hot spot CYP24A1 pathogenic variants (PVs) associated to idiopathic infantile hypercalcemia (IIH).
De Bonis M; De Paolis E; Onori ME; Mazzuccato G; Gatto A; Ferrara P; Ferraro PM; Urbani A; Minucci A
Mol Biol Rep; 2021 Apr; 48(4):3303-3311. PubMed ID: 33864587
[TBL] [Abstract][Full Text] [Related]
31. CYP24A1 Variants in Two Chinese Patients with Idiopathic Infantile Hypercalcemia.
Sun Y; Shen J; Hu X; Qiao Y; Yang J; Shen Y; Li G
Fetal Pediatr Pathol; 2019 Feb; 38(1):44-56. PubMed ID: 30633617
[TBL] [Abstract][Full Text] [Related]
32. Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report.
Kang SJ; Lee R; Kim HS
Ann Pediatr Endocrinol Metab; 2019 Mar; 24(1):64-67. PubMed ID: 30943683
[TBL] [Abstract][Full Text] [Related]
33. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
[TBL] [Abstract][Full Text] [Related]
34. 24-Hydroxylase Deficiency Due to
Azer SM; Vaughan LE; Tebben PJ; Sas DJ
J Endocr Soc; 2021 Sep; 5(9):bvab119. PubMed ID: 34337279
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of a recurrent 10.9 kb CYP24A1 deletion in Idiopathic Infantile Hypercalcemia.
Molin A; Nowoczyn M; Coudray N; Ballandone C; Abéguilé G; Mittre H; Richard N; Eckart P; Castanet M; Kottler ML
Eur J Med Genet; 2019 Nov; 62(11):103577. PubMed ID: 30423445
[TBL] [Abstract][Full Text] [Related]
36. Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.
Fencl F; Bláhová K; Schlingmann KP; Konrad M; Seeman T
Eur J Pediatr; 2013 Jan; 172(1):45-9. PubMed ID: 23001465
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia and CYP24A1 Gene Mutation Diagnosed in the 2nd Trimester of a Twin Pregnancy: A Case Report.
Romašovs A; Jaunozola L; Berga-Švītiņa E; Daneberga Z; Miklaševičs E; Pīrāgs V
Am J Case Rep; 2021 Oct; 22():e931116. PubMed ID: 34662328
[TBL] [Abstract][Full Text] [Related]
38. [Hypercalcemia and inactive mutation of CYP24A1. Case-study and literature review].
Seidowsky A; Villain C; Vilaine E; Baudoin R; Tabarin A; Kottler ML; Cavalier É; Souberbielle JC; Massy ZA
Nephrol Ther; 2017 May; 13(3):146-153. PubMed ID: 28456639
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
40. Presymptomatic diagnosis of CYP24A1-related infantile idiopathic hypercalcemia: A case report.
Mirea AM; Pop RM; Căinap SS; Trifa AP
Eur J Med Genet; 2020 Dec; 63(12):104100. PubMed ID: 33186763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
